broad_id
string | depmap_id
string | ccle_name
string | screen_id
string | upper_limit
int64 | lower_limit
float64 | slope
float64 | r2
float64 | auc
float64 | ec50
float64 | ic50
float64 | name
string | moa
string | target
string | disease.area
string | indication
string | smiles
string | phase
string | passed_str_profiling
bool | row_name
string |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BRD-K47832606-001-30-1
|
ACH-000921
|
NCIH1339_LUNG
|
HTS002
| 1 | 0.169494 | 1.82881 | 0.790841 | 0.684057 | 0.249465 | 0.312838 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000921
|
BRD-K47832606-001-30-1
|
ACH-000954
|
HEC1A_ENDOMETRIUM
|
HTS002
| 1 | 0.200005 | 2.659634 | 0.77066 | 0.557639 | 0.046732 | 0.056628 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000954
|
BRD-K47832606-001-30-1
|
ACH-000280
|
SNU840_OVARY
|
HTS002
| 1 | 0.189876 | 1.468523 | 0.947519 | 0.511865 | 0.028817 | 0.039894 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000280
|
BRD-K47832606-001-30-1
|
ACH-000012
|
HCC827_LUNG
|
HTS002
| 1 | 0.177713 | 2.886328 | 0.766551 | 0.526909 | 0.037609 | 0.043789 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000012
|
BRD-K47832606-001-30-1
|
ACH-000098
|
GAMG_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.349984 | 3.49056 | 0.351852 | 0.716399 | 0.144961 | 0.204661 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000098
|
BRD-K47832606-001-30-1
|
ACH-000589
|
NCIH1437_LUNG
|
HTS002
| 1 | 0.21324 | 1.239762 | 0.851529 | 0.520466 | 0.026811 | 0.041982 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000589
|
BRD-K47832606-001-30-1
|
ACH-000738
|
GB1_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.260991 | 2.110599 | 0.554954 | 0.696951 | 0.186989 | 0.265274 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000738
|
BRD-K47832606-001-30-1
|
ACH-000837
|
NCIH322_LUNG
|
HTS002
| 1 | 0.186471 | 2.270251 | 0.779305 | 0.573366 | 0.061638 | 0.075706 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000837
|
BRD-K47832606-001-30-1
|
ACH-000967
|
SNUC2A_LARGE_INTESTINE
|
HTS002
| 1 | 0.36318 | 4.146739 | 0.643656 | 0.651701 | 0.049543 | 0.067718 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000967
|
BRD-K47832606-001-30-1
|
ACH-000662
|
CORL23_LUNG
|
HTS002
| 1 | 0.325649 | 2.242026 | 0.536406 | 0.640754 | 0.056865 | 0.090976 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000662
|
BRD-K47832606-001-30-1
|
ACH-000427
|
NCIN87_STOMACH
|
HTS002
| 1 | 0.985824 | 0.724332 | -0.040625 | 0.992083 | 0.042747 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000427
|
BRD-K47832606-001-30-1
|
ACH-000774
|
RERFLCAD2_LUNG
|
HTS002
| 1 | 0.404402 | 2.458731 | 0.320509 | 0.861681 | 1.051848 | 2.061513 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000774
|
BRD-K47832606-001-30-1
|
ACH-000624
|
HCC1806_BREAST
|
HTS002
| 1 | 0.131288 | 1.982768 | 0.781656 | 0.40447 | 0.012893 | 0.015034 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000624
|
BRD-K47832606-001-30-1
|
ACH-000888
|
NCIH1793_LUNG
|
HTS002
| 1 | 0.62223 | 1.790772 | 0.452514 | 0.843431 | 0.179255 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000888
|
BRD-K47832606-001-30-1
|
ACH-000449
|
MESSA_SOFT_TISSUE
|
HTS002
| 1 | 0.121416 | 3.094364 | 0.70735 | 0.537901 | 0.060727 | 0.066439 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000449
|
BRD-K47832606-001-30-1
|
ACH-000587
|
NCIH1975_LUNG
|
HTS002
| 1 | 0.189755 | 2.948271 | 0.800872 | 0.538989 | 0.040002 | 0.047031 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000587
|
BRD-K47832606-001-30-1
|
ACH-000404
|
K029AX_SKIN
|
HTS002
| 1 | 0.242322 | 4.206711 | 0.421293 | 0.672698 | 0.151165 | 0.176965 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000404
|
BRD-K47832606-001-30-1
|
ACH-000813
|
T3M10_LUNG
|
HTS002
| 1 | 0.110118 | 1.884296 | 0.683038 | 0.505854 | 0.045677 | 0.052123 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000813
|
BRD-K47832606-001-30-1
|
ACH-000311
|
NCIH2122_LUNG
|
HTS002
| 1 | 0.19299 | 3.066034 | 0.626347 | 0.556452 | 0.048269 | 0.056592 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000311
|
BRD-K47832606-001-30-1
|
ACH-000849
|
MDAMB468_BREAST
|
HTS002
| 1 | 0.302233 | 4.096219 | 0.741446 | 0.652405 | 0.079537 | 0.099749 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000849
|
BRD-K47832606-001-30-1
|
ACH-000868
|
HCC1195_LUNG
|
HTS002
| 1 | 0.362891 | 4.972981 | 0.565683 | 0.626406 | 0.033783 | 0.043822 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000868
|
BRD-K47832606-001-30-1
|
ACH-000978
|
EN_ENDOMETRIUM
|
HTS002
| 1 | 1.567675 | -0.476239 | 0.123242 | 1.21921 | 0.019975 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000978
|
BRD-K47832606-001-30-1
|
ACH-000408
|
TE5_OESOPHAGUS
|
HTS002
| 1 | 0.441971 | 4.047398 | 0.663495 | 0.747628 | 0.124164 | 0.211393 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000408
|
BRD-K47832606-001-30-1
|
ACH-000344
|
SNU668_STOMACH
|
HTS002
| 1 | 0.411234 | 1.656151 | 0.689852 | 0.672819 | 0.045482 | 0.129163 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000344
|
BRD-K47832606-001-30-1
|
ACH-000161
|
CORL105_LUNG
|
HTS002
| 1 | 0.290168 | 0.953168 | 0.374065 | 0.746427 | 0.323843 | 0.805307 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000161
|
BRD-K47832606-001-30-1
|
ACH-000835
|
GCT_SOFT_TISSUE
|
HTS002
| 1 | 0.29838 | 2.329911 | 0.61829 | 0.668198 | 0.101617 | 0.150058 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000835
|
BRD-K47832606-001-30-1
|
ACH-000819
|
LN18_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.128059 | 4.740864 | 0.94249 | 0.536027 | 0.057206 | 0.06089 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000819
|
BRD-K47832606-001-30-1
|
ACH-000062
|
RERFLCMS_LUNG
|
HTS002
| 1 | 0.107584 | 3.25189 | 0.662667 | 0.579299 | 0.103096 | 0.111071 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000062
|
BRD-K47832606-001-30-1
|
ACH-000473
|
RT112_URINARY_TRACT
|
HTS002
| 1 | 0.06352 | 12.698418 | 0.824702 | 0.462981 | 0.038305 | 0.038717 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000473
|
BRD-K47832606-001-30-1
|
ACH-000176
|
LOUNH91_LUNG
|
HTS002
| 1 | 0.11798 | 2.871783 | 0.880034 | 0.488746 | 0.03607 | 0.039614 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000176
|
BRD-K47832606-001-30-1
|
ACH-000445
|
KNS60_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.196759 | 3.457669 | 0.814226 | 0.572092 | 0.056867 | 0.065716 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000445
|
BRD-K47832606-001-30-1
|
ACH-000331
|
ISTMES2_PLEURA
|
HTS002
| 1 | 0.358737 | 12.070301 | 0.372135 | 0.680629 | 0.079629 | 0.088419 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000331
|
BRD-K47832606-001-30-1
|
ACH-000163
|
SW579_THYROID
|
HTS002
| 1 | 0.164713 | 1.170134 | 0.428557 | 0.540462 | 0.047849 | 0.067328 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000163
|
BRD-K47832606-001-30-1
|
ACH-000768
|
MDAMB231_BREAST
|
HTS002
| 1 | 0.239316 | 1.960808 | 0.578707 | 0.621872 | 0.080363 | 0.112024 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000768
|
BRD-K47832606-001-30-1
| null | null |
HTS002
| 1 | 0.05041 | 0.561882 | 0.437837 | 0.303972 | 0.005249 | 0.006341 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| false |
ACH-001078_FAILED_STR
|
BRD-K47832606-001-30-1
|
ACH-000778
|
HSC3_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.074189 | 2.661799 | 0.86234 | 0.454647 | 0.032921 | 0.034968 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000778
|
BRD-K47832606-001-30-1
|
ACH-000881
|
MELJUSO_SKIN
|
HTS002
| 1 | 0.196763 | 3.503941 | 0.732898 | 0.614442 | 0.094853 | 0.109404 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000881
|
BRD-K47832606-001-30-1
|
ACH-000521
|
NCIH2030_LUNG
|
HTS002
| 1 | 0.211607 | 3.173448 | 0.713728 | 0.590132 | 0.064419 | 0.076616 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000521
|
BRD-K47832606-001-30-1
|
ACH-000696
|
OVCAR8_OVARY
|
HTS002
| 1 | 0.161941 | 1.125809 | 0.688106 | 0.608008 | 0.107136 | 0.151677 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000696
|
BRD-K47832606-001-30-1
|
ACH-000972
|
HEC151_ENDOMETRIUM
|
HTS002
| 1 | 0.276732 | 2.204517 | 0.762872 | 0.617231 | 0.058834 | 0.084812 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000972
|
BRD-K47832606-001-30-1
|
ACH-000242
|
RT4_URINARY_TRACT
|
HTS002
| 1 | 0.289187 | 2.207249 | 0.458751 | 0.587009 | 0.035591 | 0.052634 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000242
|
BRD-K47832606-001-30-1
|
ACH-000087
|
SKES1_BONE
|
HTS002
| 1 | 0.030887 | 1.886249 | 0.469147 | 0.478134 | 0.053765 | 0.055613 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000087
|
BRD-K47832606-001-30-1
|
ACH-000926
|
HT55_LARGE_INTESTINE
|
HTS002
| 1 | 0.448312 | 3.259429 | 0.579317 | 0.70061 | 0.051632 | 0.103585 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000926
|
BRD-K47832606-001-30-1
|
ACH-000356
|
MKN45_STOMACH
|
HTS002
| 1 | 0.084907 | 2.797742 | 0.756918 | 0.481494 | 0.04093 | 0.043745 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000356
|
BRD-K47832606-001-30-1
|
ACH-000625
|
HEP3B217_LIVER
|
HTS002
| 1 | 0.246606 | 1.206595 | 0.608001 | 0.633831 | 0.089541 | 0.157273 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000625
|
BRD-K47832606-001-30-1
|
ACH-000613
|
HOS_BONE
|
HTS002
| 1 | 0.138001 | 4.089765 | 0.553498 | 0.611932 | 0.126673 | 0.137082 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000613
|
BRD-K47832606-001-30-1
|
ACH-000976
|
HUCCT1_BILIARY_TRACT
|
HTS002
| 1 | 0.271249 | 3.448229 | 0.757872 | 0.588434 | 0.041676 | 0.052284 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000976
|
BRD-K47832606-001-30-1
|
ACH-001075
|
NCIH292_LUNG
|
HTS002
| 1 | 0.223213 | 1.474779 | 0.671783 | 0.50024 | 0.019356 | 0.028904 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-001075
|
BRD-K47832606-001-30-1
|
ACH-000261
|
RERFLCAI_LUNG
|
HTS002
| 1 | 0.143605 | 1.705271 | 0.770959 | 0.629339 | 0.150004 | 0.182949 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000261
|
BRD-K47832606-001-30-1
|
ACH-000957
|
LS180_LARGE_INTESTINE
|
HTS002
| 1 | 0.254328 | 1.808122 | 0.715066 | 0.507687 | 0.016478 | 0.024411 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000957
|
BRD-K47832606-001-30-1
|
ACH-000099
|
SIMA_AUTONOMIC_GANGLIA
|
HTS002
| 1 | 0.193772 | 3.632987 | 0.614956 | 0.534736 | 0.036975 | 0.042317 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000099
|
BRD-K47832606-001-30-1
|
ACH-000783
|
CAMA1_BREAST
|
HTS002
| 1 | 1.621309 | -1.298574 | -0.012204 | 1.200247 | 0.013745 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000783
|
BRD-K47832606-001-30-1
|
ACH-000573
|
MDAMB436_BREAST
|
HTS002
| 1 | 0.371764 | 14.776771 | 0.784738 | 0.689129 | 0.082143 | 0.090067 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000573
|
BRD-K47832606-001-30-1
|
ACH-000852
|
NCIH1435_LUNG
|
HTS002
| 1 | 0.56816 | 3.68613 | 0.354571 | 0.883621 | 0.731531 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000852
|
BRD-K47832606-001-30-1
|
ACH-000461
|
SNU1196_BILIARY_TRACT
|
HTS002
| 1 | 0.331582 | 5.032273 | 0.485674 | 0.709706 | 0.1478 | 0.183479 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000461
|
BRD-K47832606-001-30-1
|
ACH-000420
|
SNU449_LIVER
|
HTS002
| 1 | 0.375142 | 5.679479 | 0.516762 | 0.73405 | 0.160794 | 0.205288 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000420
|
BRD-K47832606-001-30-1
|
ACH-000694
|
TE9_OESOPHAGUS
|
HTS002
| 1 | 0.225925 | 4.221378 | 0.517611 | 0.635029 | 0.103021 | 0.118789 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000694
|
BRD-K47832606-001-30-1
|
ACH-000528
|
ABC1_LUNG
|
HTS002
| 1 | 0.393977 | 4.296893 | 0.690018 | 0.708719 | 0.094268 | 0.135246 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000528
|
BRD-K47832606-001-30-1
|
ACH-000845
|
NCIH1373_LUNG
|
HTS002
| 1 | 0.304119 | 2.175101 | 0.769603 | 0.644042 | 0.06986 | 0.107483 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000845
|
BRD-K47832606-001-30-1
|
ACH-000563
|
EBC1_LUNG
|
HTS002
| 1 | 0.083177 | 12.905709 | 0.846091 | 0.471026 | 0.037019 | 0.037545 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000563
|
BRD-K47832606-001-30-1
|
ACH-000665
|
SKMES1_LUNG
|
HTS002
| 1 | 0.216734 | 2.1144 | 0.848133 | 0.575609 | 0.052061 | 0.068112 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000665
|
BRD-K47832606-001-30-1
|
ACH-000467
|
HCC56_LARGE_INTESTINE
|
HTS002
| 1 | 0.078884 | 4.517785 | 0.761892 | 0.336164 | 0.009177 | 0.009533 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000467
|
BRD-K47832606-001-30-1
|
ACH-000201
|
A204_SOFT_TISSUE
|
HTS002
| 1 | 0.161277 | 2.014529 | 0.722435 | 0.541032 | 0.049402 | 0.059937 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000201
|
BRD-K47832606-001-30-1
|
ACH-000296
|
OUMS23_LARGE_INTESTINE
|
HTS002
| 1 | 0.440999 | 2.476938 | 0.500134 | 0.774147 | 0.19827 | 0.469848 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000296
|
BRD-K47832606-001-30-1
|
ACH-000189
|
RCC10RGB_KIDNEY
|
HTS002
| 1 | 0.207143 | 1.580282 | 0.761001 | 0.595156 | 0.070472 | 0.09886 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000189
|
BRD-K47832606-001-30-1
|
ACH-000791
|
RERFLCAD1_LUNG
|
HTS002
| 1 | 0.292718 | 6.46605 | 0.653089 | 0.671678 | 0.110574 | 0.126706 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000791
|
BRD-K47832606-001-30-1
|
ACH-000367
|
NCIH226_LUNG
|
HTS002
| 1 | 0.258068 | 3.407205 | 0.809815 | 0.641351 | 0.091781 | 0.113576 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000367
|
BRD-K47832606-001-30-1
|
ACH-001190
|
SKMEL2_SKIN
|
HTS002
| 1 | 0.374845 | 9.348433 | 0.460362 | 0.688212 | 0.079088 | 0.091718 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-001190
|
BRD-K47832606-001-30-1
|
ACH-000244
|
DKMG_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.280163 | 3.83528 | 0.784052 | 0.605943 | 0.049307 | 0.061089 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000244
|
BRD-K47832606-001-30-1
|
ACH-000713
|
CAOV3_OVARY
|
HTS002
| 1 | 0.0616 | 9.608751 | 0.778583 | 0.55478 | 0.100111 | 0.10149 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000713
|
BRD-K47832606-001-30-1
|
ACH-000672
|
IALM_LUNG
|
HTS002
| 1 | 0.322105 | 4.114544 | 0.439721 | 0.690545 | 0.119163 | 0.153186 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000672
|
BRD-K47832606-001-30-1
|
ACH-000875
|
NCIH2347_LUNG
|
HTS002
| 1 | 0.169215 | 0.698842 | 0.556681 | 0.620551 | 0.122471 | 0.221198 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000875
|
BRD-K47832606-001-30-1
|
ACH-000423
|
SKMEL3_SKIN
|
HTS002
| 1 | 0.585987 | 4.551335 | 0.490775 | 0.809744 | 0.115691 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000423
|
BRD-K47832606-001-30-1
|
ACH-000553
|
SQ1_LUNG
|
HTS002
| 1 | 0.40791 | 4.88194 | 0.516194 | 0.718773 | 0.0996 | 0.140852 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000553
|
BRD-K47832606-001-30-1
|
ACH-000834
|
UMUC1_URINARY_TRACT
|
HTS002
| 1 | 0.119878 | 1.820252 | 0.718027 | 0.418062 | 0.016323 | 0.018976 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000834
|
BRD-K47832606-001-30-1
|
ACH-000252
|
LS1034_LARGE_INTESTINE
|
HTS002
| 1 | 0.513032 | 3.974213 | 0.306433 | 0.74386 | 0.060709 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000252
|
BRD-K47832606-001-30-1
|
ACH-000123
|
COV434_OVARY
|
HTS002
| 1 | 0.026299 | 0.579829 | 0.523142 | 0.439563 | 0.034051 | 0.037376 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000123
|
BRD-K47832606-001-30-1
|
ACH-000329
|
CCFSTTG1_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | 0.232952 | 1.495068 | 0.511267 | 0.62411 | 0.086058 | 0.130911 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000329
|
BRD-K47832606-001-30-1
|
ACH-000717
|
COLO680N_OESOPHAGUS
|
HTS002
| 1 | 0.215787 | 1.49487 | 0.702824 | 0.624773 | 0.0963 | 0.140521 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000717
|
BRD-K47832606-001-30-1
|
ACH-000669
|
SW900_LUNG
|
HTS002
| 1 | 0.222897 | 1.103438 | 0.475873 | 0.508519 | 0.021245 | 0.036271 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000669
|
BRD-K47832606-001-30-1
|
ACH-000764
|
SH10TC_STOMACH
|
HTS002
| 1 | 0.232884 | 1.690393 | 0.8222 | 0.595064 | 0.059603 | 0.086365 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000764
|
BRD-K47832606-001-30-1
|
ACH-000288
|
BT549_BREAST
|
HTS002
| 1 | 0.050668 | 1.127577 | 0.762202 | 0.438258 | 0.031796 | 0.034956 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000288
|
BRD-K47832606-001-30-1
|
ACH-000415
|
BICR6_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.111429 | 1.250427 | 0.417703 | 0.50168 | 0.043172 | 0.052817 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000415
|
BRD-K47832606-001-30-1
|
ACH-000228
|
BICR31_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.306331 | 5.717314 | 0.71968 | 0.664541 | 0.0916 | 0.108129 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000228
|
BRD-K47832606-001-30-1
|
ACH-000977
|
LNCAPCLONEFGC_PROSTATE
|
HTS002
| 1 | 0.128318 | 3.397889 | 0.803044 | 0.61664 | 0.140127 | 0.152907 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000977
|
BRD-K47832606-001-30-1
|
ACH-000397
|
TEN_ENDOMETRIUM
|
HTS002
| 1 | 0.405271 | 1.231733 | 0.279145 | 0.734059 | 0.130819 | 0.504931 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000397
|
BRD-K47832606-001-30-1
|
ACH-000565
|
RCM1_LARGE_INTESTINE
|
HTS002
| 1 | 0.162122 | 10.840679 | 0.820163 | 0.497962 | 0.029841 | 0.030939 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000565
|
BRD-K47832606-001-30-1
|
ACH-000209
|
SNU1079_BILIARY_TRACT
|
HTS002
| 1 | 0.16796 | 4.372262 | 0.568134 | 0.601762 | 0.096129 | 0.105564 |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000209
|
BRD-K47832606-001-30-1
|
ACH-000927
|
BT474_BREAST
|
HTS002
| 1 | 0.536892 | 3.307949 | 0.326276 | 0.781048 | 0.101734 | null |
floxuridine
|
DNA synthesis inhibitor
|
TYMS
|
oncology
|
colorectal cancer
|
OC[C@H]1OC(C[C@H]1O)n1cc(F)c(=O)[nH]c1=O, OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O
|
Launched
| true |
ACH-000927
|
BRD-K72951360-001-01-4
|
ACH-000879
|
MFE296_ENDOMETRIUM
|
HTS002
| 1 | 0.052323 | 2.445771 | 0.626228 | 0.656293 | 0.296161 | 0.309853 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000879
|
BRD-K72951360-001-01-4
|
ACH-000320
|
PSN1_PANCREAS
|
HTS002
| 1 | 0.027715 | 4.411637 | 0.784023 | 0.651509 | 0.308635 | 0.312651 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000320
|
BRD-K72951360-001-01-4
|
ACH-001145
|
OC316_OVARY
|
HTS002
| 1 | 0.008265 | 3.272199 | 0.794123 | 0.505583 | 0.079241 | 0.079646 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-001145
|
BRD-K72951360-001-01-4
|
ACH-000873
|
KYSE270_OESOPHAGUS
|
HTS002
| 1 | 0.006584 | 2.419384 | 0.785497 | 0.59165 | 0.185201 | 0.186219 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000873
|
BRD-K72951360-001-01-4
|
ACH-000855
|
KYSE150_OESOPHAGUS
|
HTS002
| 1 | 0.086549 | 1.969422 | 0.759049 | 0.617227 | 0.171418 | 0.188786 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000855
|
BRD-K72951360-001-01-4
|
ACH-000913
|
ESS1_ENDOMETRIUM
|
HTS002
| 1 | 0.060678 | 17.259716 | 0.39966 | 0.80946 | 1.396727 | 1.407236 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000913
|
BRD-K72951360-001-01-4
|
ACH-000558
|
A172_CENTRAL_NERVOUS_SYSTEM
|
HTS002
| 1 | -0.013869 | 2.079351 | 0.402281 | 0.826771 | 1.88962 | 1.864919 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000558
|
BRD-K72951360-001-01-4
|
ACH-000593
|
BC3C_URINARY_TRACT
|
HTS002
| 1 | -0.014205 | 1.236688 | 0.553545 | 0.752404 | 0.943959 | 0.922817 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000593
|
BRD-K72951360-001-01-4
|
ACH-000488
|
TE11_OESOPHAGUS
|
HTS002
| 1 | 0.000024 | 2.556876 | 0.801478 | 0.630702 | 0.277716 | 0.277721 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000488
|
BRD-K72951360-001-01-4
|
ACH-000832
|
CAL27_UPPER_AERODIGESTIVE_TRACT
|
HTS002
| 1 | 0.000425 | 1.298922 | 0.729522 | 0.647558 | 0.329519 | 0.329735 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000832
|
BRD-K72951360-001-01-4
|
ACH-000781
|
NCIH2023_LUNG
|
HTS002
| 1 | 0.03628 | 2.046344 | 0.57614 | 0.707443 | 0.526182 | 0.545912 |
valrubicin
|
DNA inhibitor, topoisomerase inhibitor
|
TOP2A
|
oncology
|
bladder cancer
|
CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)c2c(O)c3C(=O)c4c(OC)cccc4C(=O)c3c(O)c2C1
|
Launched
| true |
ACH-000781
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.